MX2009002787A - Composiciones y métodos para prevenir el cáncer con cupredoxinas. - Google Patents

Composiciones y métodos para prevenir el cáncer con cupredoxinas.

Info

Publication number
MX2009002787A
MX2009002787A MX2009002787A MX2009002787A MX2009002787A MX 2009002787 A MX2009002787 A MX 2009002787A MX 2009002787 A MX2009002787 A MX 2009002787A MX 2009002787 A MX2009002787 A MX 2009002787A MX 2009002787 A MX2009002787 A MX 2009002787A
Authority
MX
Mexico
Prior art keywords
compositions
cupredoxins
tissues
animals
development
Prior art date
Application number
MX2009002787A
Other languages
English (en)
Spanish (es)
Inventor
Ananda Chakrabarty
Gupta Tapas Das
Original Assignee
Univ Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Illinois filed Critical Univ Illinois
Publication of MX2009002787A publication Critical patent/MX2009002787A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/104—Pseudomonadales, e.g. Pseudomonas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
MX2009002787A 2006-09-14 2007-09-13 Composiciones y métodos para prevenir el cáncer con cupredoxinas. MX2009002787A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84435806P 2006-09-14 2006-09-14
PCT/US2007/078371 WO2008033987A2 (en) 2006-09-14 2007-09-13 Compositions and methods to prevent cancer with cupredoxins

Publications (1)

Publication Number Publication Date
MX2009002787A true MX2009002787A (es) 2009-08-27

Family

ID=39184582

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009002787A MX2009002787A (es) 2006-09-14 2007-09-13 Composiciones y métodos para prevenir el cáncer con cupredoxinas.

Country Status (13)

Country Link
EP (1) EP2061498A4 (enExample)
JP (2) JP2010503409A (enExample)
KR (1) KR20090059152A (enExample)
CN (1) CN101595124A (enExample)
AU (1) AU2007296429A1 (enExample)
BR (1) BRPI0714987A2 (enExample)
CA (1) CA2663498A1 (enExample)
IL (1) IL197602A0 (enExample)
MX (1) MX2009002787A (enExample)
NO (1) NO20091267L (enExample)
RU (1) RU2009113812A (enExample)
SG (1) SG174784A1 (enExample)
WO (1) WO2008033987A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7556810B2 (en) 2005-07-19 2009-07-07 The Board Of Trustees Of The University Of Ilinois Compositions and methods to control angiogenesis with cupredoxins
US9096663B2 (en) 2001-02-15 2015-08-04 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof
US7381701B2 (en) 2001-02-15 2008-06-03 The Borad Of Trustees Of The University Of Illinois Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
AP2007003959A0 (en) 2004-10-07 2007-04-30 Ananda Chakrabarty Cupredoxin derived transport agents and methods ofuse thereof
US9968685B2 (en) 2004-10-07 2018-05-15 Brad N. Taylor Methods to treat cancer with cupredoxins
US10675326B2 (en) 2004-10-07 2020-06-09 The Board Of Trustees Of The University Of Illinois Compositions comprising cupredoxins for treating cancer
US9598470B2 (en) * 2004-10-07 2017-03-21 Craig W. Beattie Compositions and methods to prevent cancer by stabilizing P53 through non MDM2-mediated pathways
US9434770B2 (en) 2004-10-07 2016-09-06 Tapas K Das Gupta Modified cupredoxin derived peptides
MX2008000994A (es) 2005-07-19 2008-03-19 Univ Illinois Agentes de transporte para cruzar la barrera hematoencefalica y hacia el interior de las celulas de cancer cerebral, y metodos para el uso de los mismos.
KR20090095626A (ko) 2006-12-04 2009-09-09 더 보드 오브 트러스티즈 오브 더 유니버시티 오브 일리노이 쿠프레독신과 ＣｐＧ 리치 ＤＮＡ를 이용한 조성물 및 암 치료 방법
AU2008212788A1 (en) 2007-02-08 2008-08-14 The Board Of Trustees Of The University Of Illinois Compositions and methods to prevent cancer with cupredoxins
KR102718038B1 (ko) * 2017-09-29 2024-10-16 온크그노스틱스 게엠베하 신생물증 및 암에 대한 위험 결정

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7491394B2 (en) * 2001-02-15 2009-02-17 The Board Of Trustees Of The University Of Illinois Cytotoxic factors for modulating cell death
CN1506375A (zh) * 2002-12-12 2004-06-23 浙江养生堂天然药物研究所有限公司 具有广谱抗肿瘤作用的细菌蛋白天青蛋白及其用途和含有其的药物组合物
AP2007003959A0 (en) * 2004-10-07 2007-04-30 Ananda Chakrabarty Cupredoxin derived transport agents and methods ofuse thereof
CA2608512A1 (en) * 2005-05-20 2007-02-15 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
KR20080034905A (ko) * 2005-07-19 2008-04-22 더 보드 오브 트러스티즈 오브 더 유니버시티 오브 일리노이 쿠프레독신으로 혈관신생을 제어하는 조성물과 방법

Also Published As

Publication number Publication date
AU2007296429A1 (en) 2008-03-20
IL197602A0 (en) 2011-08-01
EP2061498A2 (en) 2009-05-27
WO2008033987A3 (en) 2009-04-30
JP2010503409A (ja) 2010-02-04
CA2663498A1 (en) 2008-03-20
KR20090059152A (ko) 2009-06-10
RU2009113812A (ru) 2010-10-20
BRPI0714987A2 (pt) 2013-07-30
CN101595124A (zh) 2009-12-02
WO2008033987A2 (en) 2008-03-20
JP2014050390A (ja) 2014-03-20
SG174784A1 (en) 2011-10-28
NO20091267L (no) 2009-06-04
EP2061498A4 (en) 2009-11-04

Similar Documents

Publication Publication Date Title
WO2008033987A3 (en) Compositions and methods to prevent cancer with cupredoxins
TW200714590A (en) Heterocyclic inhibitors of MEK and methods of use thereof
WO2009109927A3 (en) Glp-1 receptor agonists and related active pharmaceutical ingredients for treatment of cancer
ECSP11011297A (es) Proteinas ligadoras il-17
MY146969A (en) Dpp iv inhibitor formulations
CL2007000161A1 (es) Compuestos derivados de 2,4-dioxoimidazolidina sustituida, inhibidores de proteinas cinasas; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer.
CL2007000789A1 (es) Compuestos derivados de malonamida, inhibidores de la gamma-secretasa; proceso de preparacion; composicion farmaceutica; y su uso en el tratamiento de la enfermedad de alzheimer.
MX2009010034A (es) Pirimidodiazepinas sustituidas utiles inhibidores de la plk1.
MY153198A (en) Inhibitors of protein aggregation
WO2009038689A3 (en) Compositions and methods for diagnosis and treatment of type 2 diabetes
MX2009005455A (es) (r)-n-estereoisomeros de analogos de 7,8-saturados-4,5 epoxi-morfinano.
UA100840C2 (ru) Композиция для лечения вирусного гепатита
WO2008030273A3 (en) Compositions and methods for diagnosis and treatment of type 2 diabetes
GEP20135724B (en) Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for treatment or prevention of diabetes
EP3718560A3 (en) Cyclin dependent kinase inhibitors and methods of use
EA201001223A1 (ru) Стабилизированные белковые композиции
EA200800555A1 (ru) Производные ксантина в качестве селективных агонистов hm74a
MX2009005460A (es) (s)-n-estereoisomeros de analogos de 7,8-saturados-4,5-epoxi-morfi nano.
TW200728305A (en) Spiropiperidine beta-sectetase inhibitors for the treatment of alzheimer's disease
WO2009025196A1 (ja) Foxm1ペプチドおよびこれを含む薬剤
TNSN08367A1 (en) Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
TW200735890A (en) Compositions and methods for increasing insulin sensitivity
WO2008011071A3 (en) Interactions of hedgehog and liver x receptor signaling pathways
GB0718957D0 (en) Optical imaging agents
WO2008054698A3 (en) Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease

Legal Events

Date Code Title Description
FA Abandonment or withdrawal